From: Potential of CRISPR/Cas system as emerging tools in the detection of viral hepatitis infection
Types of Hepatitis | Platform Name | Cas Protein | Amplification Methods | Visualization | Sensitivity | Times | References |
---|---|---|---|---|---|---|---|
HBV | CRISPRHBV | Cas12b | MCDA | Real-time/ Fluorescence | 10 copies/µL | 60 min | [91] |
- | Cas13a | RCA/PCR | Fluorescence | 1 copy/µL | - | [92] | |
PCR-CRISPR | Cas13a | PCR | Fluorescence | 1 copy/µL | 15 min | [93] | |
 |  |  | Fluorescent |  | 13 min |  | |
LAMP-Cas12a-based HBV | Cas12a | LAMP | Lateral flow test strips | 1 copy/µL | 20 min | [94] | |
HCV | RT-LAMP-Coupled CRISPR–Cas12 | Cas12a | RT-LAMP | Fluorescent/ Lateral flow test strips | 10 ng/µL | - | [97] |